Insight Molecular Diagnostics names Donnie Purto SVP Sales
IMDX•Insight Molecular Diagnostics appointed Donnie Purto senior vice president of sales to lead commercialization ahead of the planned GraftAssureDx launch; the test remains under FDA review.
1. Sales leadership appointment
Insight Molecular Diagnostics appointed Donnie Purto as senior vice president of sales to lead commercialization ahead of the planned GraftAssureDx launch. Purto has more than 20 years of diagnostics, life sciences and healthcare sales experience, including a decade in senior commercial roles at Natera.
2. Product review
GraftAssureDx is an in vitro diagnostic kit for donor-derived cell-free DNA testing in transplant care and remains under FDA medical device review.
